PMCB

PharmaCyte Biotech (PMCB)

PharmaCyte Biotech Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PMCB

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/02/15	05:38	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:PMCB	PharmaCyte Biotech Inc
2024/02/06	23:56	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/12/16	07:25	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/11/29	07:06	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/11/25	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/11/23	07:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/11/23	07:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/11/23	07:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/11/23	07:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/11/23	07:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/11/23	07:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/11/23	06:00	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/11/15	22:30	Business Wire	PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/11/10	07:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/10/31	22:15	Business Wire	PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/10/31	22:15	Business Wire	PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/10/02	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/09/22	06:04	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/09/18	19:04	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/09/16	06:00	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/09/12	10:56	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/09/08	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/08/05	05:40	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/08/05	05:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/08/01	06:18	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/08/01	05:42	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/07/19	23:28	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/06/17	06:23	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/06/16	05:02	Edgar (US Regulatory)	Amended Tender Offer Statement by Issuer (sc To-i/a)	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/06/15	22:15	Business Wire	PharmaCyte Biotech Announces Final Results of Tender Offer	NASDAQ:PMCB	PharmaCyte Biotech Inc